The Medicare Part D market continues to shift in ways that significantly impact managed care companies, pharmaceutical manufacturers, policymakers, and people who rely on Medicare for their prescription drugs. With over 1.6 million low-income beneficiaries in a state of transition, questions about “intelligent assignment” have resurfaced.  The further proliferation of private fee-for-service and special needs plans sets up a potential conflict between marketplace demand and congressional concern.  As plans seek to cement their market positions, maintain customer loyalty, and strive for profitability, formulary management will become an even more critical part of health plans’ business strategies. 

This 90-minute, interactive Avalere Health audio conference will explore:

• Avalere Health’s analyses of the new CMS Medicare data, including an in-depth look at soon-to-be-released formulary-level data
• Health plan perspectives on opportunities and challenges of operating in the Medicare arena
• A view from the government of potential areas for future Medicare reforms
• How changes to health plans will bear a direct impact on the patient community

• Bob Atlas, Senior Vice President, Avalere Health
• Abby Block, Director, Center for Beneficiary Choices, Centers for Medicare and Medicaid Services
• TBA Health Plan Perspective
• Penny Mills, Vice President, Avalere Health (moderator)

Registration Prices :
Avalere Client	$300
Commercial	$375
Government	$50
Hill Staff	Complimentary
Non-profit	Special rates apply*

Cancellation Policy: To receive a refund, notice is required at least seven business days prior to the audio conference. With proper notice, fees are refunded minus a $40 service fee. No refunds are given for cancellations received with less than seven days notice. Avalere Health reserves the right to cancel or reschedule an audio conference due to unforeseen circumstances.